Biography
I am currently appointed as Acting Dean of the Rotterdam School of Management (RSM) and as professor of Health Economics at the Erasmus School of Health Policy & Management (ESHPM), both of the Erasmus University Rotterdam.
My research is mainly focused on the methodology of welfare economic evaluations of health interventions, but I am also interested in topics like behavioral health economics and public health economics. An overview of publications can be found here:
https://scholar.google.nl/citations?user=A57xZTEAAAAJ&hl=en
I have been involved in the development, coordination and teaching of several bachelor and master courses and am happy to have supervised around 25 completed PhD theses, and to be able to supervise around 10 current PhD students.
I am an Associate Editor of Health Economics and a member of the Editorial Boards of the European Journal of Health Economics, PharmacoEconomics and Cost-Effectiveness and Resource Allocation. Moreover, I was a co-founder of the Health Economics Study Group for the Low Lands (LoLaHESG), of the Erasmus Initiative Smarter Choices for Better Health, and of the Erasmus Center of Health Economics Rotterdam (EsCHER). Furthermore, amongst other ancillary activities, I serve as the independent chairman of the Foundation for Top Clinical Mental Health Care (TOPGGz), am a Trustee of the Office of Health Economics (London, UK), and am Chair of the Supervisory Board of the institute of Medical Technology Assessment BV.
Previously, I served as the Dean of ESHPM from 2012 to 2018 and as interim Dean of ESHPM from December 2019 to May 2022, and amongst others as Head of the Health Economics & Health Technology Assessment Department, Research Director of ESHPM, and as Academic Lead of the Erasmus Initiative Smarter Choices for Better Health.
Erasmus School of Health Policy & Management
- brouwer@eshpm.eur.nl
- Location
- Burg. Oudlaan 50, Rotterdam
More information
Work
- Bram Wouterse, Pieter van Baal, Matthijs Versteegh & Werner Brouwer (2023) - The Value of Health in a Cost-Effectiveness Analysis: Theory Versus Practice - PharmacoEconomics, 41 (6), 607-617 - doi: 10.1007/s40273-023-01265-8 - [link]
- Rosanna Tarricone, Helen Banks, Oriana Ciani, Werner Brouwer, Michael F. Drummond, Reiner Leidl, Nicolas Martelli, Laura Sampietro-Colom & Rod S. Taylor (2023) - An accelerated access pathway for innovative high-risk medical devices under the new European Union Medical Devices and health technology assessment regulations?: Analysis and recommendations - Expert Review of Medical Devices, 20 (4), 259-271 - doi: 10.1080/17434440.2023.2192868 - [link]
- Werner Brouwer, Kaya Verbooy, Renske Hoefman & Job van Exel (2023) - Production Losses due to Absenteeism and Presenteeism: The Influence of Compensation Mechanisms and Multiplier Effects - PharmacoEconomics - doi: 10.1007/s40273-023-01253-y - [link]
- , Valérie van Hezik-Wester, Saskia de Groot, Tim Kanters, Matthijs Versteegh, Louis Wagner, Jacqueline Ardesch, Werner Brouwer & Job van Exel (2022) - Burden of illness in people with medically refractory epilepsy who suffer from daily to weekly seizures: 12-month follow-up of participants in the EPISODE study - Frontiers in Neurology, 13 - doi: 10.3389/fneur.2022.1012486 - [link]
- Meg Perry-Duxbury, Sebastian Himmler, Job van Exel & Werner Brouwer (2022) - Willingness to pay for health gains from an international integrated early warning system for infectious disease outbreaks - European Journal of Health Economics - doi: 10.1007/s10198-022-01527-w - [link]
- Sandor Kovács, Zoltán Kaló, Rita Daubner-Bendes, Katarzyna Kolasa, Rok Hren, Tomas Tesar, Vivian Reckers-Droog, Werner Brouwer, Carlo Federici, Mike Drummond & Antal Tamás Zemplényi (2022) - Implementation of coverage with evidence development schemes for medical devices: A decision tool for late technology adopter countries - Health Economics (United Kingdom), 31 (S1), 195-206 - doi: 10.1002/hec.4504 - [link]
- Arthur E. Attema, Werner B.F. Brouwer & Jose Luis Pinto (2022) - The Role of Perceived Utility of Full Health in Age Weighting - Value in Health, 25 (9), 1559-1565 - doi: 10.1016/j.jval.2022.04.1733 - [link]
- Sebastian Himmler, Marcel Jonker, Frédérique van Krugten, Mariska Hackert, Job van Exel & Werner Brouwer (2022) - Estimating an anchored utility tariff for the well-being of older people measure (WOOP) for the Netherlands - Social Science & Medicine, 301 - doi: 10.1016/j.socscimed.2022.114901 - [link]
- Sebastian Himmler, Job van Exel & WBF (Werner) Brouwer (2022) - Did the COVID-19 pandemic change the willingness to pay for an early warning system for infectious diseases in Europe? - European Journal of Health Economics, 23 (1), 81-94 - doi: 10.1007/s10198-021-01353-6 - [link]
- SPI (Samare) Huls, A (Ayesha) Sajjad, TA (Tim) Kanters, L (Leona) Hakkaart - van Roijen, WBF (Werner) Brouwer & NJA (Job) van Exel (2022) - Productivity of Working at Home and Time Allocation Between Paid Work, Unpaid Work and Leisure Activities During a Pandemic - PharmacoEconomics, 40 (1), 77-90 - doi: 10.1007/s40273-021-01078-7 - [link]
European Journal Health Economics
- Start date approval
- november 2020
- End date approval
- november 2023
- Place
- NA
- Description
- Lid Editorial Board
Health Economics
- Start date approval
- november 2020
- End date approval
- november 2023
- Place
- YORK
- Description
- Associate Editor
Zorginstituut Nederland
- Start date approval
- november 2020
- End date approval
- november 2023
- Place
- DIEMEN
- Description
- Lid Wetenschappelijke AdviesRaad Zinl
BMC journal Cost-effectiveness Res Alloc
- Start date approval
- februari 2021
- End date approval
- februari 2024
- Place
- NA
- Description
- Member Editorial Board
European Journal Health Economics
- Start date approval
- februari 2021
- End date approval
- februari 2024
- Place
- NA
- Description
- Lid Editorial Board
Health Economics
- Start date approval
- februari 2021
- End date approval
- februari 2024
- Place
- YORK
- Description
- Associate Editor
PharmacoEconomics
- Start date approval
- februari 2021
- End date approval
- februari 2024
- Place
- NZ
- Description
- Lid Editorial Board
Stichting TOPGGz
- Start date approval
- februari 2021
- End date approval
- februari 2024
- Place
- AMERSFOORT
- Description
- Voorzitter
Zorginstituut Nederland
- Start date approval
- februari 2021
- End date approval
- februari 2024
- Place
- DIEMEN
- Description
- Lid Wetenschappelijke AdviesRaad Zinl
institute for Medical Technology Assessm
- Start date approval
- februari 2021
- End date approval
- februari 2024
- Place
- ROTTERDAM
- Description
- Member Supervisory Board
Stichting Erasmus Trustfonds
- Start date approval
- oktober 2021
- End date approval
- oktober 2024
- Place
- ROTTERDAM
- Description
- lid bestuur
Stichting Veens Welzijn
- Start date approval
- oktober 2021
- End date approval
- oktober 2024
- Place
- VEENENDAAL
- Description
- Voorzitter Raad van Toezicht
zonmw
- Start date approval
- oktober 2021
- End date approval
- oktober 2024
- Place
- DEN HAAG
- Description
- lid programmacommissie/beoordelingscommissie
Charity Office of Health Economics
- Start date approval
- januari 2022
- End date approval
- december 2024
- Place
- LONDEN
- Description
- Member Board of Trustees OHE
Patientenfederatie Nederland
- Start date approval
- juni 2023
- End date approval
- mei 2026
- Place
- UTRECHT
- Description
- lid Raad van Toezicht
Patientenfederatie Nederland
- Start date approval
- juni 2023
- End date approval
- juni 2026
- Place
- UTRECHT
- Description
- lid raad van toezicht Patientenfederatie Nederland
Rationing Health Care
- Level
- Bachelor 3
- Year Level
- Bachelor 3
- Year
- 2022
- Course Code
- GW301
Health Economics
- Year Level
- bachelor 3, bachelor 3, bachelor 3, bachelor 3
- Year
- 2022
- Course Code
- FEB13053
Acting Dean
- Start date approval
- februari 2023